Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Research C for DE and. FDA approves first treatment for fibrodysplasia ossificans progressiva. FDA. Published online August 17, 2023. Accessed 8 Nov 2023. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-treatment-fibrodysplasia-ossificans-progressiva
2. Sohonos | European Medicines Agency. Accessed 3 Jan 2024. https://www.ema.europa.eu/en/medicines/human/EPAR/sohonos#ema-inpage-item-news-on
3. Scarlett RF, Rocke DM, Kantanie S, Patel JB, Shore EM, Kaplan FS. Influenza-like viral illnesses and flare-ups of fibrodysplasia ossificans progressiva. Clin Orthop. 2004;423:275–9. https://doi.org/10.1097/01.blo.0000129557.38803.26.
4. Kaplan FS, Zasloff MA, Kitterman JA, Shore EM, Hong CC, Rocke DM. Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am. 2010;92(3):686–91. https://doi.org/10.2106/JBJS.I.00705.
5. Shimono K, Tung WE, Macolino C, et al. Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists. Nat Med. 2011;17(4):454–60. https://doi.org/10.1038/nm.2334.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献